EIF2AK3 and metabolic dysfunction-associated steatohepatitis: We demonstrated that the expression of CHOP was reduced in NASH mice upon pan PPAR-iMSC-EVs administration, with a concomitant interruption of PERK, IRE1α, and ATF6, which are upstream inducers of CHOP (Fig. 6A–C).